Cargando…
Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
OBJECTIVE: To evaluate contezolid (MRX-I) antibacterial activity against Mycobacterium abscessus in vitro and in vivo and to assess whether MRX-I treatment can prolong survival of infected zebrafish. METHODS: MRX-I inhibitory activity against M. abscessus in vitro was assessed by injecting MRX-I int...
Autores principales: | Gao, Shan., Nie, Wenjuan., Liu, Lina., Su, Lei., You, Yingxia., Geng, Ruixue., Chu, Naihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465794/ https://www.ncbi.nlm.nih.gov/pubmed/37655300 http://dx.doi.org/10.3389/fcimb.2023.1225341 |
Ejemplares similares
-
Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus
por: Nie, Wenjuan, et al.
Publicado: (2023) -
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro
por: Guo, Qi, et al.
Publicado: (2021) -
Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients
por: Wang, Jun, et al.
Publicado: (2023) -
In vitro activities of contezolid (MRX-I) against drug-sensitive and drug-resistant Mycobacterium tuberculosis
por: An, Huiru, et al.
Publicado: (2023) -
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen
por: Victoria, Laura, et al.
Publicado: (2021)